Cargando…
Dieckol inhibits non‐small–cell lung cancer cell proliferation and migration by regulating the PI3K/AKT signaling pathway
Non‐small–cell lung cancer (NSCLC) is one of the most prevalent type of lung cancers with an increased mortality rate in both developed and developing countries worldwide. Dieckol is one such polyphenolic drug extracted from brown algae which has proven antioxidant and anti‐inflammatory properties....
Autores principales: | Wang, Chun‐Hong, Li, Xiao‐Feng, Jin, Li‐Fang, Zhao, Yan, Zhu, Geng‐Jun, Shen, Wei‐Zhang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771741/ https://www.ncbi.nlm.nih.gov/pubmed/31291034 http://dx.doi.org/10.1002/jbt.22346 |
Ejemplares similares
-
Dieckol exerts anticancer activity in human osteosarcoma (MG-63) cells through the inhibition of PI3K/AKT/mTOR signaling pathway
por: Zhang, Shouqiang, et al.
Publicado: (2021) -
EGCG inhibited bladder cancer T24 and 5637 cell proliferation and migration via PI3K/AKT pathway
por: Luo, Ke-Wang, et al.
Publicado: (2018) -
PAQR3 inhibits proliferation via suppressing PI3K/AKT signaling pathway in non-small cell lung cancer
por: Li, Xiaohui, et al.
Publicado: (2017) -
Celastrol inhibits the proliferation and migration of MCF-7 cells through the leptin-triggered PI3K/AKT pathway
por: Chen, Pingping, et al.
Publicado: (2022) -
Down-Regulation of SREBP via PI3K/AKT/mTOR Pathway Inhibits the Proliferation and Invasion of Non-Small-Cell Lung Cancer Cells
por: Zhang, Bo, et al.
Publicado: (2020)